Cargando…

Stationary Trend in Elevated Serum Alpha-Fetoprotein Level in Hepatocellular Carcinoma Patients

SIMPLE SUMMARY: In this study, we demonstrated that overall 51.2% of patients with hepatocellular carcinoma (HCC) had elevated alpha-fetoprotein (AFP) levels. The proportion of patients with elevated AFP levels was stationary in the period from 2011 to 2020. The proportion of patients with Barcelona...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yen, Yi-Hao, Kee, Kwong-Ming, Li, Wei-Feng, Liu, Yueh-Wei, Wang, Chih-Chi, Hu, Tsung-Hui, Tsai, Ming-Chao, Lin, Chih-Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954058/ https://www.ncbi.nlm.nih.gov/pubmed/36831565 http://dx.doi.org/10.3390/cancers15041222

Ejemplares similares

Alpha-Fetoprotein Combined with Radiographic Tumor Burden Score to Predict Overall Survival after Liver Resection in Hepatocellular Carcinoma
por: Yen, Yi-Hao, et al.
Publicado: (2023)

Clinical relevance of alpha-fetoprotein in determining resection margin for hepatocellular carcinoma
por: Lee, Jin-Chiao, et al.
Publicado: (2019)

Normal Alpha-Fetoprotein Hepatocellular Carcinoma: Are They Really Normal?
por: Lee, Chao-Wei, et al.
Publicado: (2019)

Serum alpha-fetoprotein as a predictive biomarker for tissue alpha-fetoprotein status and prognosis in patients with hepatocellular carcinoma
por: Wei, Zhewen, et al.
Publicado: (2022)

Risk Score Model for Microvascular Invasion in Hepatocellular Carcinoma: The Role of Tumor Burden and Alpha-Fetoprotein
por: Lee, Jin-Chiao, et al.
Publicado: (2021)

Differential alternative splicing between hepatocellular carcinoma with normal and elevated serum alpha-fetoprotein
por: Jin, Young-Joo, et al.
Publicado: (2020)

Causes of Death among Patients with Hepatocellular Carcinoma According to Chronic Liver Disease Etiology
por: Yen, Yi-Hao, et al.
Publicado: (2023)

Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab
por: Zhu, Andrew X., et al.
Publicado: (2021)

Alpha-Fetoprotein Ratio Predicts Alpha-Fetoprotein Positive Hepatocellular Cancer Patient Prognosis after Hepatectomy
por: Sun, Li-Yue, et al.
Publicado: (2022)

Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha‐fetoprotein levels
por: Hsu, Po‐Yao, et al.
Publicado: (2021)

Quantitative proteomic profiling of hepatocellular carcinoma at different serum alpha-fetoprotein level
por: Wei, Xuyong, et al.
Publicado: (2022)

Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity
por: Wang, Xiaoping, et al.
Publicado: (2018)

The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis
por: Arrieta, Oscar, et al.
Publicado: (2007)

Potential of ramucirumab in treating hepatocellular carcinoma patients with elevated baseline alpha-fetoprotein
por: Gilabert, Marine, et al.
Publicado: (2018)

Gastric adenosquamous carcinoma with an elevated serum level of alpha-fetoprotein: A case report
por: Sun, Liang, et al.
Publicado: (2023)

The Landscape Of Alpha Fetoprotein In Hepatocellular Carcinoma: Where Are We?
por: Hu, Xin, et al.
Publicado: (2022)

Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma.
por: Tsai, J. F., et al.
Publicado: (1995)

Clinical Significance of Alpha-Fetoprotein in Alpha-Fetoprotein Negative Hepatocellular Carcinoma Underwent Curative Resection
por: Lin, Kongying, et al.
Publicado: (2021)

Elevation of Serum Alpha‐fetoprotein and Proliferation of Oval Cells in the Livers of LEC Rats
por: Takahashi, Hidetoshi, et al.
Publicado: (1988)

Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients
por: Liang, Kung-Hao, et al.
Publicado: (2021)

Regulation Effect of Zinc Fingers and Homeoboxes 2 on Alpha-Fetoprotein in Human Hepatocellular Carcinoma
por: Hu, Shao Wei, et al.
Publicado: (2013)

The Emerging Influences of Alpha-Fetoprotein in the Tumorigenesis and Progression of Hepatocellular Carcinoma
por: Xu, Ye, et al.
Publicado: (2021)

Infantile mesenchymal hamartoma of the liver with elevated alpha fetoprotein
por: Le, Liem Thanh, et al.
Publicado: (2021)

Racial disparities in alpha‐fetoprotein testing and alpha‐fetoprotein status associated with the diagnosis and outcome of hepatocellular carcinoma patients
por: Wu, Guoyi, et al.
Publicado: (2019)

Hepatoid adenocarcinoma of the stomach: an unusual case of elevated alpha-fetoprotein with prior treatment for hepatocellular carcinoma
por: Ahn, Joon Seong, et al.
Publicado: (2013)

Serum exosomal microRNAs combined with alpha‐fetoprotein as diagnostic markers of hepatocellular carcinoma
por: Wang, Yurong, et al.
Publicado: (2018)

Continued value of the serum alpha-fetoprotein test in surveilling at-risk populations for hepatocellular carcinoma
por: An, Jihyun, et al.
Publicado: (2020)

The alpha-fetoprotein serum is still reliable as a biomarker for the surveillance of hepatocellular carcinoma in Indonesia
por: Jasirwan, Chyntia Olivia Maurine, et al.
Publicado: (2020)

Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma
por: Hanif, Hira, et al.
Publicado: (2022)

Serum metabolites may be useful markers to assess vascular invasion and identify normal alpha-fetoprotein in hepatocellular carcinoma undergoing liver resection: a pilot study
por: Lee, Chao-Wei, et al.
Publicado: (2020)

Quantitative mass spectrometric analysis of hepatocellular carcinoma biomarker alpha-fetoprotein
por: Chen, Chen-Chun, et al.
Publicado: (2023)

Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection
por: Tsai, Ming-Chao, et al.
Publicado: (2019)

Elevated Serum Levels of Alpha-Fetoprotein in Patients with Infantile Hemangioma Are Not Derived from within the Tumor
por: Itinteang, Tinte, et al.
Publicado: (2016)

Intrahepatic Cholangiocarcinoma in a Patient with Alcoholic Liver Cirrhosis and Markedly Elevated Serum Alpha-Fetoprotein
por: Romero, Ana L., et al.
Publicado: (2023)

Enhanced Detection of Early Hepatocellular Carcinoma by Serum SELDI-TOF Proteomic Signature Combined with Alpha-Fetoprotein Marker
por: Chen, Lei, et al.
Publicado: (2010)

Ramucirumab for Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha Fetoprotein Following Non–Sorafenib Systemic Therapy: An Expansion Cohort of REACH-2
por: Finn, Richard S, et al.
Publicado: (2022)

Mesenchymal Hamartoma With Elevated Alpha-Fetoprotein: A Diagnostic Pitfall
por: Naggar, Amine, et al.
Publicado: (2023)

Elevated serum alpha-fetoprotein in poorly differentiated adenocarcinoma with neuroendocrine differentiation of the ascending colon: a case report
por: Lin, Hung-Hsin, et al.
Publicado: (2016)

Dynamic Change in Serum Alpha-fetoprotein Level Predicts Treatment Response and Prognosis of Alpha-fetoprotein-producing Gastric Cancer
por: Wang, Ruhan, et al.
Publicado: (2020)

Clinical evaluation of urinary transforming growth factor-beta1 and serum alpha-fetoprotein as tumour markers of hepatocellular carcinoma.
por: Tsai, J. F., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_ud67bltruaepjtsiikp6uf2l1f